RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0045-1811968
Phenotype to Genotype: A Novel Case Presentation of CPT2 Deficiency Syndrome
Autoren
Abstract
Prenatal detection of recurrent structural anomalies presents complex challenges in fetal prognosis and genetic counseling. We report the case of a 25-year-old woman with three consecutive pregnancies affected by bilateral hyperechoic, enlarged fetal kidneys and associated anomalies. In the first pregnancy, anomaly scan at 18 + 6 weeks revealed enlarged hyperechoic kidneys, Dandy-Walker malformation, and echogenic bowel. The pregnancy was terminated; microarray analysis was normal. A year later, her second pregnancy showed similar renal findings along with enlarged lateral ventricles, absent cavum septum pellucidum, and microcephaly. Trio whole-exome sequencing identified compound heterozygous variants in the CPT2 gene in the fetus: c.28_29insAGCAAG and c.1891C > T. Both parents were found to be heterozygous carriers. In the third pregnancy, clinical exome sequencing was offered as prenatal testing despite a normal ultrasound. The fetus was initially reported as “affected” with the same compound heterozygous CPT2 variants. However, reanalysis by a clinical geneticist revealed that both variants were in cis configuration in the parents and fetus, indicating a carrier status rather than disease. This case underscores the importance of detailed variant interpretation, phase determination, and expert genetic counseling in managing suspected fetal CPT2 deficiency, especially in cases presenting with recurrent antenatal anomalies.
Keywords
CPT2 gene - fetal renal anomalies - prenatal diagnosis - compound heterozygosity - genetic counselingPublikationsverlauf
Artikel online veröffentlicht:
03. Oktober 2025
© 2025. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Carr MC, Benacerraf BR, Estroff JA, Mandell J. Prenatally diagnosed bilateral hyperechoic kidneys with normal amniotic fluid: postnatal outcome. J Urol 1995; 153 (02) 442-444
- 2 Krensky AM, Reddish JM, Teele RL. Causes of increased renal echogenicity in pediatric patients. Pediatrics 1983; 72 (06) 840-846
- 3 Tsatsaris V, Gagnadoux MF, Aubry MC, Gubler MC, Dumez Y, Dommergues M. Prenatal diagnosis of bilateral isolated fetal hyperechogenic kidneys. Is it possible to predict long term outcome?. BJOG 2002; 109 (12) 1388-1393
- 4 Surányi A, Retz C, Rigo J, Schaaps JP, Foidart JM. Fetal renal hyperechogenicity in intrauterine growth retardation: importance and outcome. Pediatr Nephrol 2001; 16 (07) 575-580
- 5 Lehmann D, Motlagh L, Robaa D, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features. Int J Mol Sci 2017; 18 (01) 82
- 6 Ramirez Pujadas A, Bagan Robledo H, Soulliman N, Guillemat Font Y, Aragon Casalet P, Gil Romero E. Prenatal Diagnosis of Carnitine Palmitoyltransferase II Deficiency.
- 7 Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 2004; 25 (5-6): 495-520
- 8 Bonnefont JP, Demaugre F, Prip-Buus C. et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 1999; 68 (04) 424-440
- 9 DiMauro S, DiMauro PM. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 1973; 182 (4115): 929-931
- 10 Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991; 325 (26) 1862-1864
- 11 Gellera C, Benke PJ, Cavadini P. et al. Lethal carnitine palmitoyltransferase II deficiency in newborns: a molecular-genetic study. In: Coates PM, Tanaka K. eds. New Development in Fatty Acid Oxidation. New York: Wiley-Liss; 1992: 301-308
- 12 Vekemans BC, Bonnefont JP, Aupetit J. et al. Prenatal diagnosis of carnitine palmitoyltransferase 2 deficiency in chorionic villi: a novel approach. Prenat Diagn 2003; 23 (11) 884-887
- 13 Pierce MR, Pridjian G, Morrison S, Pickoff AS. Fatal carnitine palmitoyltransferase II deficiency in a newborn: new phenotypic features. Clin Pediatr (Phila) 1999; 38 (01) 13-20
- 14 Sharma R, Perszyk AA, Marangi D, Monteiro C, Raja S. Lethal neonatal carnitine palmitoyltransferase II deficiency: an unusual presentation of a rare disorder. Am J Perinatol 2003; 20 (01) 25-32
- 15 Smeets RJ, Smeitink JA, Semmekrot BA, Scholte HR, Wanders RJ, van den Heuvel LP. A novel splice site mutation in neonatal carnitine palmitoyl transferase II deficiency. J Hum Genet 2003; 48 (01) 8-13
- 16 Joshi PR, Zierz S. Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach. Molecules 2020; 25 (08) 1784
- 17 Deschauer M, Wieser T, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 2005; 62 (01) 37-41
- 18 Joshi PR, Deschauer M, Zierz S. Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: a questionnaire-based survey. J Clin Neurosci 2019; 59: 32-36
- 19 Kaneoka H, Uesugi N, Moriguchi A. et al. Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF. Am J Kidney Dis 2005; 45 (03) 596-602